Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Ironwood Pharmaceuticals Company Profile (NASDAQ:IRWD)

Consensus Ratings for Ironwood Pharmaceuticals (NASDAQ:IRWD) (?)
Ratings Breakdown: 5 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.55)
Consensus Price Target: $16.06 (13.36% upside)

Analysts' Ratings History for Ironwood Pharmaceuticals (NASDAQ:IRWD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/21/2014ZacksReiterated RatingNeutral -> Neutral$14.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2014Cowen and CompanyDowngradeOutperform -> Market Perform$16.00 -> $10.50ViewTweet This Rating  Share This Rating on StockTwits
8/6/2014ZacksReiterated RatingNeutral -> Neutral$14.00ViewTweet This Rating  Share This Rating on StockTwits
8/5/2014Leerink SwannReiterated RatingMarket Perform$15.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
7/9/2014Furey Research PartnersInitiated CoverageBuy$20.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2014MizuhoBoost Price TargetBuy$17.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
6/18/2014WallachBeth CapitalInitiated CoverageHold$16.00ViewTweet This Rating  Share This Rating on StockTwits
5/19/2014Leerink SwannBoost Price TargetMarket Perform$12.15 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
4/30/2014JPMorgan Chase & Co.Reiterated RatingOverweight$22.00ViewTweet This Rating  Share This Rating on StockTwits
4/30/2014Cantor FitzgeraldReiterated RatingHold$11.00ViewTweet This Rating  Share This Rating on StockTwits
4/29/2014AegisReiterated RatingBuy -> PositiveViewTweet This Rating  Share This Rating on StockTwits
4/23/2014Bank of AmericaUpgradeBuyViewTweet This Rating  Share This Rating on StockTwits
3/18/2014AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
1/22/2014MizuhoBoost Price TargetBuy$15.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014BMO Capital MarketsUpgradeMarket Perform -> OutperformViewTweet This Rating  Share This Rating on StockTwits
10/24/2013Jefferies GroupLower Price TargetHold$12.00 -> $11.00ViewTweet This Rating  Share This Rating on StockTwits
10/24/2013Cowen and CompanyUpgradeMarket Perform -> Outperform$14.00ViewTweet This Rating  Share This Rating on StockTwits
10/23/2013WedbushLower Price TargetNeutral$12.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
10/23/2013Cantor FitzgeraldLower Price TargetHold$10.00 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
9/23/2013Leerink SwannInitiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
9/23/2013BMO Capital MarketsInitiated CoverageMarket Perform$15.00ViewTweet This Rating  Share This Rating on StockTwits
9/17/2013Goldman SachsInitiated CoverageSellViewTweet This Rating  Share This Rating on StockTwits
9/11/2013MizuhoLower Price TargetBuy$23.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2013AegisLower Price TargetBuy$17.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
7/24/2013Jefferies GroupLower Price TargetHold$15.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
7/24/2013Janney Montgomery ScottUpgradeNeutral -> BuyViewTweet This Rating  Share This Rating on StockTwits
7/24/2013Cantor FitzgeraldUpgradeSell -> Hold$7.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2013WedbushReiterated RatingHold$12.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2013Cantor FitzgeraldLower Price TargetSell$9.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
6/21/2013Credit SuisseInitiated CoverageOutperform$16.00 -> $11.31ViewTweet This Rating  Share This Rating on StockTwits
5/30/2013WedbushUpgradeUnderperform -> Neutral$12.00ViewTweet This Rating  Share This Rating on StockTwits
5/6/2013Cowen and CompanyDowngradeOutperform -> NeutralViewTweet This Rating  Share This Rating on StockTwits
4/24/2013Cantor FitzgeraldLower Price Target$12.00 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
4/24/2013Morgan StanleyDowngradeOverweight -> Equal Weight$21.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
4/24/2013WedbushDowngradeNeutral -> Underperform$13.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
4/23/2013AegisLower Price TargetBuy$19.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
3/15/2013Credit SuisseUpgradeNeutral -> Outperform$15.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
3/13/2013Cantor FitzgeraldBoost Price TargetSell$7.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
3/12/2013Bank of AmericaReiterated RatingNeutral$15.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2013WedbushUpgradeUnderperform -> Neutral$11.00 -> $13.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2013Janney Montgomery ScottInitiated CoverageNeutral$14.00ViewTweet This Rating  Share This Rating on StockTwits
1/16/2013WallachBeth CapitalBoost Price TargetHold$10.00 -> $13.00ViewTweet This Rating  Share This Rating on StockTwits
1/16/2013MizuhoBoost Price TargetBuy$22.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
1/15/2013Ladenburg ThalmannBoost Price TargetBuy$16.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
1/15/2013AegisBoost Price TargetBuy$18.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2012WallachBeth CapitalInitiated CoverageHoldViewTweet This Rating  Share This Rating on StockTwits
12/18/2012Cantor FitzgeraldBoost Price TargetSell$7.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
11/20/2012Cantor FitzgeraldLower Price TargetSell$8.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
11/9/2012MizuhoInitiated CoverageBuy$22.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/31/2012 forward)
Discuss Ironwood Pharmaceuticals